Equillium (EQ) Net Income towards Common Stockholders (2018 - 2026)

Equillium's (EQ) quarterly Net Income towards Common Stockholders came in at -$15.9 million in Q1 2026, down 81.36% year-on-year from -$85.6 million in Q1 2025, and down 298.58% on a QoQ basis from -$4.0 million in Q4 2025.

Equillium (EQ) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

Equillium (EQ) has 9 years of Net Income towards Common Stockholders data on file, last reported at -$15.9 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 81.36% year-over-year to -$15.9 million in Q1 2026; TTM through Mar 2026 was -$34.8 million, a 145.52% decrease from a year earlier, with the FY2025 full-year figure at -$22.4 million, down 176.31% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$15.9 million, down from -$4.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for EQ reached as high as $17.9 million in Q4 2022 and fell as low as -$37.4 million in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$6.7 million across 5 years, with a median of -$4.0 million in 2025.
  • Across the five-year window, Net Income towards Common Stockholders surged 268.26% in 2022 and slumped 124528.57% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at $17.9 million in 2022, then plunged by 119.9% to -$3.6 million in 2023, then sank by 63.66% to -$5.8 million in 2024, then jumped by 31.41% to -$4.0 million in 2025, then slumped by 298.58% to -$15.9 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$15.9 million in Q1 2026, -$4.0 million in Q4 2025, and -$8.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -625.73
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -0.68
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 366.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Equillium 242.14 Mn 242.14 Mn - -15.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.95 Mn
Dec 31, 2025 -4.00 Mn
Sep 30, 2025 -8.72 Mn
Jun 30, 2025 -6.11 Mn
Mar 31, 2025 -8.79 Mn
Dec 31, 2024 -5.83 Mn
Sep 30, 2024 -7,000.00
Jun 30, 2024 468,000.00
Mar 31, 2024 -2.73 Mn
Dec 31, 2023 -3.56 Mn
Sep 30, 2023 -3.71 Mn
Jun 30, 2023 -3.34 Mn
Mar 31, 2023 -3.94 Mn
Dec 31, 2022 17.91 Mn
Sep 30, 2022 -13.66 Mn
Jun 30, 2022 -14.13 Mn
Mar 31, 2022 -37.42 Mn
Dec 31, 2021 -10.64 Mn
Sep 30, 2021 -18.89 Mn
Jun 30, 2021 -14.73 Mn